Premium financing emerges as a game-changer for India’s insurance renewal retention

In India, premium financing solutions are transforming insurance sales and renewals by making policy payments more manageable, potentially boosting policy persistency and broadening customer access.

In India’s insurance market, the sale often fails not because the cover is unattractive, but because the payment feels too large to handle in one go. A customer may accept the value of health, life or motor protection, yet still hesitate when asked to pay the full annual premium at once, especially if that bill lands alongside school fees, medical expenses or other household obligations. That basic cash-flow problem is one reason policy sales can look healthy at the point of issue but weaken later at renewal, according to reporting from Insurance Times and related ShopSe analysis.

The persistence challenge is not confined to one line of business. Insurance Times cited a reply in the Rajya Sabha from the Ministry of Finance showing that life insurers’ 13th-month persistency ratios ranged from about 60% to 83%, before falling to roughly 22% to 59% by the 61st month. The same pattern shows up elsewhere: health premiums often rise at renewal, while motor customers may downgrade to third-party-only cover or let protection lapse altogether when another expense arrives at the same time. In effect, the industry has improved distribution and underwriting, but the moment of payment has remained stubbornly old-fashioned.

That is where premium financing comes in. In this model, a regulated lender pays the insurer the full premium upfront, while the policyholder repays the lender in monthly instalments, usually over three to 12 months. ShopSe says this differs from insurers’ own “accelerated EMI” options because the insurer does not need to change its balance sheet or rework product filings; the financing sits outside the insurance contract and simply makes the purchase easier to manage. Moneycontrol has separately noted that consumers considering such options should still compare the total cost, repayment flexibility and interest burden before choosing a route.

The bigger issue, however, may be the way the option is presented to agents. According to ShopSe’s own material, a single-lender setup often leads to unnecessary rejections because one lender’s criteria may not suit a particular customer’s bureau profile or income pattern. Once an agent has spent time on an application only for it to fail, the financing feature can quickly lose credibility on the ground. ShopSe argues that multi-lender architecture is more effective: one form can check eligibility across several banks and non-banking lenders at once, improving the odds of approval and reducing the time needed for decision-making.

For insurers, the commercial case is broader than just a higher conversion rate. Premium financing can help customers buy more suitable cover, because a monthly figure is psychologically easier to absorb than a lump sum. It can also reduce lapses at renewal, support higher sum assured choices and keep more policies in force, which matters in a market where persistency is a key quality metric. ShopSe’s case study of a large Indian health insurer suggests the shift can be material: approval rates improved markedly after the company moved from a single financier to a waterfall of lenders, checkout conversion rose and decision times fell from hours to under 90 seconds.

The wider lesson is that insurance distribution in India may be only partly a product problem. Just as digital underwriting and instant issuance changed how policies are sold, payment design is becoming a more important lever for growth and retention. Industry commentary from ShopSe and independent finance coverage points to the same conclusion: when affordability is treated as part of the sales journey, not an afterthought, insurers can reach customers who would otherwise walk away before the conversation properly begins.

Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.